EUVIMEDEUVIMED entdecken
Crossref

Improved drug transfer into brain tissue via the “nose-to-brain” approach using suspension or powder formulations based on the amorphous solid dispersion technique

Susumu Suwabe, Tatsuaki Tagami, Koki Ogawa, Tetsuya Ozeki

European Journal of Pharmaceutics and Biopharmaceutics · 2023-04 · 185 · 137-147

DOI: 10.1016/j.ejpb.2023.02.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2023-04. Verfasst von Susumu Suwabe und 3 weiteren Autor:innen. Beteiligte Einrichtung: Drug Delivery and Nano Pharmaceutics, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, Aichi 4…. Hauptthemen laut MEDLINE: Chemistry, Pharmaceutical, Water. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Japan Science and Technology Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Intranasal administration has attracted increasing attention as a drug delivery approach based on nose-to-brain drug delivery from the nasal cavity to brain tissue directly, bypassing the blood-brain barrier. However, application of the method to poorly water-soluble drugs is potentially limited due to low aqueous solubility and dissolution, which can hinder drug transfer to brain tissue. In the present study, we focused on an amorphous solid dispersion (ASD) technique to improve drug dissolution. A carbamazepine-loaded ASD model drug was prepared using the solvent evaporation method (ASD-1). After screening six water-soluble polymer carriers, polyvinyl alcohol (PVA)-based ASD-1 formulation exhibited the most rapid and highest drug dissolution under experimental conditions in the nasal cavity (pH 6.0). A carbamazepine suspension dispersed with a PVA-ASD-1 formulation exhibited enhanced drug delivery into plasma and brain tissue of rats in vivo. A spray-dried powder formulation of PVA-ASD (PVA-ASD-2) exhibited improved drug dissolution and in vivo drug transfer. Our key finding is that the spray-dried PVA-ASD-2 formulation exhibited higher brain/plasma ratios than the PVA-ASD-1 suspension formulation. Our physical characterization data and demonstration of improved drug transfer suggest that ASD-based intranasal formulations hold promise for drug delivery to the brain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemistry, PharmaceuticalWaterRatsAnimalsPharmaceutical PreparationsPowdersCrystallizationSolubilityDrug LiberationBrainDrug Compounding

Stichwörter der Autor:innen

Amorphous solid dispersionCarbamazepineIntranasal administrationNose-to-brain deliverySpray-drying

Substanzen

Pharmaceutical PreparationsPowdersWater

Autor:innen und Institutionen

  • Drug Delivery and Nano Pharmaceutics, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, Aichi 467-8603, Japan.
  • Drug Delivery and Nano Pharmaceutics, Graduate School of Pharmaceutical Sciences, Nagoya City University, 3-1 Tanabe-dori, Mizuho-ku, Nagoya, Aichi 467-8603, Japan. Electronic address: ozekit@phar.nagoya-cu.ac.jp.

Förderung

  • Japan Science and Technology Agency

Zitieren

APA

Suwabe, S., Tagami, T., Ogawa, K., & Ozeki, T. (2023). Improved drug transfer into brain tissue via the “nose-to-brain” approach using suspension or powder formulations based on the amorphous solid dispersion technique. European Journal of Pharmaceutics and Biopharmaceutics, 185, 137-147. https://doi.org/10.1016/j.ejpb.2023.02.012

Vancouver

Suwabe S, Tagami T, Ogawa K, Ozeki T. Improved drug transfer into brain tissue via the “nose-to-brain” approach using suspension or powder formulations based on the amorphous solid dispersion technique. European Journal of Pharmaceutics and Biopharmaceutics. 2023;185:137-147. doi:10.1016/j.ejpb.2023.02.012

BibTeX
@article{Suwabe2023,
  author = {Suwabe, Susumu and Tagami, Tatsuaki and Ogawa, Koki and Ozeki, Tetsuya},
  title = {Improved drug transfer into brain tissue via the “nose-to-brain” approach using suspension or powder formulations based on the amorphous solid dispersion technique},
  journal = {European Journal of Pharmaceutics and Biopharmaceutics},
  year = {2023},
  volume = {185},
  pages = {137--147},
  doi = {10.1016/j.ejpb.2023.02.012}
}
Kostenlos starten →